William W Lockwood (William Lockwood)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Advanced Non Small Cell Lung Cancer

Induced Apoptosis

Tyrosine Kinase

Endoplasmic Reticulum

Top Venues

British journal of cancer

Journal of translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Peiyao Wang, Raymond Ng, Stephen Lam, William W Lockwood
Uncovering molecular features driving lung adenocarcinoma heterogeneity in patients who formerly smoked. Journal of translational medicine 22 (1) (2024)
Peiyao Wang, Raymond Ng, Stephen Lam, William W Lockwood
Uncovering molecular features driving lung adenocarcinoma heterogeneity in patients who formerly smoked. Journal of translational medicine 22 (1) (2024)
Amy L Nagelberg, Tianna S Sihota, Yu-Chi Chuang, Rocky Shi, Justine L M Chow, John English, Calum MacAulay, Stephen Lam, Wan L Lam, William W Lockwood
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response. British journal of cancer (2024)
Amy L Nagelberg, Tianna S Sihota, Yu-Chi Chuang, Rocky Shi, Justine L M Chow, John English, Calum MacAulay, Stephen Lam, Wan L Lam, William W Lockwood
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response. British journal of cancer 131 (3) (2024)
Amy L Nagelberg, Tianna S Sihota, Yu-Chi Chuang, Rocky Shi, Justine L M Chow, John English, Calum MacAulay, Stephen Lam, Wan L Lam, William W Lockwood
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response. British journal of cancer 131 (3) (2024)
Amy L Nagelberg, Tianna S Sihota, Yu-Chi Chuang, Rocky Shi, Justine L M Chow, John English, Calum MacAulay, Stephen Lam, Wan L Lam, William W Lockwood
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response. British journal of cancer 131 (3) (2024)
Yibo Xue, Jordan L Morris, Kangning Yang, Zheng Fu, Xianbing Zhu, Fraser Johnson, Brian Meehan, Leora Witkowski, Amber Yasmeen, Tunde Golenar, Mackenzie Coatham, Geneviève Morin, Anie Monast, Virginie Pilon, Pierre Olivier Fiset, Sungmi Jung, Anne V Gonzalez, Sophie Camilleri-Broët, Lili Fu, Lynne-Marie Postovit, Jonathan D Spicer, Walter H Gotlieb, Marie-Christine Guiot, Janusz Rak, Morag Park, William W Lockwood, William D Foulkes, Julien Prudent, Sidong Huang
Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca 2+ flux to mitochondria. Nature communications 14 (1) (2023)
Yibo Xue, Jordan L Morris, Kangning Yang, Zheng Fu, Xianbing Zhu, Fraser Johnson, Brian Meehan, Leora Witkowski, Amber Yasmeen, Tunde Golenar, Mackenzie Coatham, Geneviève Morin, Anie Monast, Virginie Pilon, Pierre Olivier Fiset, Sungmi Jung, Anne V Gonzalez, Sophie Camilleri-Broët, Lili Fu, Lynne-Marie Postovit, Jonathan D Spicer, Walter H Gotlieb, Marie-Christine Guiot, Janusz Rak, Morag Park, William W Lockwood, William D Foulkes, Julien Prudent, Sidong Huang
Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca 2+ flux to mitochondria. Nature communications 14 (1) (2023)
Peiyao Wang, Sophie Sun, Stephen Lam, William W Lockwood
New insights into the biology and development of lung cancer in never smokers-implications for early detection and treatment. Journal of translational medicine 21 (1) (2023)
Dylan A Farnsworth, Yusuke Inoue, Fraser D Johnson, Georgia de Rappard-Yuswack, Daniel Lu, Rocky Shi, Lok In Josephine Ma, Marissa S Mattar, Romel Somwar, Marc Ladanyi, Arun M Unni, William W Lockwood
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression. NPJ precision oncology 6 (1) (2022)
Yusuke Inoue, Ana Nikolic, Dylan A Farnsworth, Rocky Shi, Fraser D Johnson, Alvin Liu, Marc Ladanyi, Romel Somwar, Marco Gallo, William W Lockwood
Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer. eLife 10 (2021)
Yibo Xue, Jordan L Morris, Kangning Yang, Zheng Fu, Xianbing Zhu, Fraser Johnson, Brian Meehan, Leora Witkowski, Amber Yasmeen, Tunde Golenar, Mackenzie Coatham, Geneviève Morin, Anie Monast, Virginie Pilon, Pierre Olivier Fiset, Sungmi Jung, Anne V Gonzalez, Sophie Camilleri-Broët, Lili Fu, Lynne-Marie Postovit, Jonathan D Spicer, Walter H Gotlieb, Marie-Christine Guiot, Janusz Rak, Morag Park, William W Lockwood, William D Foulkes, Julien Prudent, Sidong Huang
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria. Nature communications 12 (1) (2021)
Jack Calder, Amy Nagelberg, Jennifer Luu, Daniel Lu, William W Lockwood
Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4. Oncogenesis 10 (3) (2021)
Arun M Unni, Bryant Harbourne, Min Hee Oh, Sophia Wild, John R Ferrarone, William W Lockwood, Harold Varmus
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells. eLife 7 (2018)